BDBM674213 N-({(1r,4r)-4-[6- (1-cyclopropyl- 1H-pyrazol-4-yl)-2H- indazol-2-yl] cyclohexyl}methyl)- 3,5-difluoro-4- hydroxybenzamide::US20240150334, Example 43

SMILES O=C(NC[C@H]1CC[C@H](n2cc3ccc(-c4cnn(C5CC5)c4)cc3n2)CC1)c1cc(F)c(O)c(F)c1

InChI Key InChIKey=YYJSCNPDAGSJKI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 674213   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Smith, Gambrell & Russell

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 674213BDBM674213(N-({(1r,4r)-4-[6- (1-cyclopropyl- 1H-pyrazol-4-yl)...)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of human HSD17B13 using estradiol and NAD as substrate incubated for 2 hrs by Envision plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Smith, Gambrell & Russell

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 674213BDBM674213(N-({(1r,4r)-4-[6- (1-cyclopropyl- 1H-pyrazol-4-yl)...)
Affinity DataIC50: 6.5nMAssay Description:HSD17B13 uses the oxidized form of nicotinamide adenine dinucleotide (NAD+) as a cofactor during metabolism of beta-estradiol (substrate), converting...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2024
Entry Details
US Patent